Axena Health

Axena Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $65M

Overview

Axena Health is a private, commercial-stage digital health and medical device company based in Newton, Massachusetts, founded in 2019. It has successfully launched the Leva Pelvic Health System, a prescription digital therapeutic that uses a vaginal motion sensor and smartphone app to guide pelvic floor muscle training for incontinence. The company emphasizes strong clinical evidence, real-world data, and strategic access initiatives, such as securing coverage for female veterans through the VA. Axena is positioned in the large and growing market for women's pelvic health, aiming to redefine the standard of care with its non-drug, non-surgical solution.

Women's Pelvic HealthUrinary IncontinenceFecal Incontinence

Technology Platform

The Leva® Pelvic Health System: an FDA-cleared, prescription digital therapeutic platform combining a vaginal motion sensor (medical device) with a smartphone application. It provides guided, biofeedback-enabled pelvic floor muscle training for at-home treatment of urinary and fecal incontinence.

Funding History

2
Total raised:$65M
Series B$40M
Series A$25M

Opportunities

The large, underserved, and growing market for women's pelvic health conditions presents a major opportunity, especially with an aging population.
Successful penetration of federal healthcare systems (like the VA) provides a blueprint for expanding into other large payer networks.
The global shift towards digital health and value-based care creates a favorable environment for clinically proven, non-invasive digital therapeutics.

Risk Factors

Commercial success is heavily dependent on securing widespread insurance reimbursement beyond initial wins like the VA.
The company faces increasing competition in the digital pelvic health space from both startups and established medtech firms.
As a young commercial company, execution risks in scaling sales, support, and manufacturing while maintaining capital efficiency are significant.

Competitive Landscape

Axena Health competes in the pelvic floor digital therapeutic and device market. Competitors include other prescription digital therapeutics for UI (e.g., Renovia's leva system, now part of Hologic), various pelvic floor training apps, and traditional medical device companies offering in-office biofeedback systems. Axena's differentiation hinges on its specific FDA clearances, clinical evidence package, and its integrated hardware-software approach designed for the home setting.